The "Nebulizer Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis ...
An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, ...
Blincyto's label has gradually been extended since 2014, and in December the MHRA approved it as the first immunotherapy for ...
BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
Telangana Chief Minister A. Revanth Reddy, Union Commerce and Industry Minister Piyush Goyal, G20 Sherpa Amitabh Kant and ...
The three main US share market indices—the Dow Jones Industrial Average (DJIA), the S&P 500 and the Nasdaq Composite—closed a ...
Shares of Amgen Inc. AMGN advanced 1.24% to $297.93 Thursday, on what proved to be an all-around dismal trading session for ...
"I am pleased to be joining Terns as we advance our lead oncology and obesity programs towards important clinical readouts ...
Bio Asia 2025 will feature high-impact sessions, panel discussions, and networking opportunities, engaging thought leaders, ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results